A new LUMC study has changed our understanding of how cells work. Researchers have discovered that the CFAP20 protein acts as ...

We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...

More than 9 out of 10 Alzheimer's cases could be driven by specific variations in a single gene and the protein it produces, ...

In an important new study, Chinese researchers have discovered the previously unrecognized role of alternative splicing of ...

Precision and timing of gene expression is essential for normal biological functions and, when disrupted, can lead to many ...

In a groundbreaking study published in the in Proceedings of the National Academy of Sciences (PNAS), scientists at Pacific ...

The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

One gene called APOE has long been known to increase the risk of Alzheimer’s disease, but without a specific variant most ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

Cell cycle checkpoint-related genes (CCCRGs) are implicated in the development and progression of hepatocellular carcinoma ...